HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Intraperitoneal infusion of a nonabsorbable steroid in hemodialysis-associated ascites.

Abstract
Ascites occurring in long-term hemodialysis patients continues to be a difficult management problem. Several modalities have been employed with varying success. Because of the similarities between uremic pericardial effusion and hemodialysis-associated ascites, infusion of the nonabsorbable steroid, triamcinolone hexacetonide, was attempted in five patients with the latter ailment which had become intractable. None of the patients responded and in two there were adverse effects. We conclude that for the management of this variety of ascites, intraperitoneal administration of a nonabsorbable steroid is ineffective and may be accompanied by undesirable reactions.
AuthorsV K Bansal, S Popli, T S Ing, J E Hano, W P Geis, M R Kamadana
JournalJournal of dialysis (J Dial) Vol. 2 Issue 4 Pg. 379-85 ( 1978) ISSN: 0362-8558 [Print] United States
PMID721992 (Publication Type: Journal Article)
Chemical References
  • Triamcinolone Acetonide
Topics
  • Ascites (etiology)
  • Humans
  • Infusions, Parenteral
  • Renal Dialysis (adverse effects)
  • Triamcinolone Acetonide (administration & dosage, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: